1. Home
2. Quality Improvement
3. CKD QI Programme

Chronic Kidney Disease Quality Improvement Programme

This programme was solely funded by Bayer PLC. Bayer PLC were not involved in the development of the programme, content, selection of speakers or their arrangements. All content was independently developed by PCCS.

This Quality Improvement (QI) programme is designed to support primary care teams to understand the importance of Chronic Kidney Disease (CKD), how to improve coding, embedding processes to detect CKD, and how to optimise patients with CKD.

The programme covers the following four modules: 

•  Module 1: CKD Prevention and diagnosis

•  Module 2: Coding and searches

•  Module 3: Treatment and management ~ updated in June 2024 

  • Boehringer Ingelheim has provided funding for the update of module 3 however, they have had no input into the development of the content, selection of speakers or their arrangements. All content has been independently developed by the PCCS. 

•  Module 4: Preparing for end stage renal disease/dialysis

These modules were filmed in April 2023. Module 3 was updated in June 2024 following updates in national guidance. 

---

Introduction to the CKD QI Programme: 

 

The information provided in this presentation is for educational purposes only. Prescribing or management decisions made by clinicians are exclusively their own responsibility. The speaker/PCCS bear no responsibility regarding management or prescribing decisions made by others, or otherwise.

 

Please take the time to watch the 4 modules in this programme

---